Yahoo Web Search

Search results

  1. www.sanofi.com.sg › en › productsCORDARONE - Sanofi

    You are about to leave sanofi.com.sg If you wish to access one of our Group website from another country, click Proceed. Medical practices and regulations can be different from one country to another.

  2. You are about to leave sanofi.com.sg If you wish to access one of our Group website from another country, click Proceed. Medical practices and regulations can be different from one country to another.

  3. sanofi-aventis singapore pte ltd, 38 beach road #18-11, south beach tower, singapore 189767. date of revision of the text apr 2023 . created date:

  4. [SANOFI LOGO] This package insert is continually updated: please read carefully before using a new pack. In case of any question, please contact your physician or pharmacist. Composition . Each Amaryl tablet contains, as active ingredient, 1mg or 2 mg or 3 mg glimepiride.

  5. SG/PLA/0520/CCDSV13 3 Chronic cardiac toxicity Cases of cardiomyopathy resulting in cardiac failure, in some cases with fatal outcome, have been reported in patients treated with Plaquenil (see section 4.8 and 4.9).

  6. SG/MenQ/0323/EU SmPC0223 1 NAME OF THE MEDICINAL PRODUCT. MenQuadfi solution for injection . Meningococcal Group A, C, W and Y conjugate vaccine . QUALITATIVE AND QUANTITATIVE COMPOSITION

  7. Sanofi Pasteur Product Information 323 - Dengvaxia SG/DEN/1022/CCDSv6 Page 1 of 19 1 NAME OF THE MEDICINAL PRODUCT Dengvaxia, powder and solvent for suspension for injection. Dengue tetravalent vaccine (live, attenuated). 2 QUALITATIVE AND QUANTITATIVE COMPOSITION After reconstitution, one dose (0.5 mL) contains:

  8. 6* +(; 6p3& glvhdvh 1hyhuwkhohvv ydfflqdwlrq ri lqglylgxdov zlwk fkurqlf lppxqrghilflhqf\ vxfk dv +,9 lqihfwlrq lv uhfrpphqghg hyhq li wkh dqwlerg\ uhvsrqvh pd\ eh olplwhg

  9. SG/TYPSD/0622/SmPC1220 4 CLINICAL PARTICULARS 4.1 Therapeutic indications Prevention of typhoid fever in adults and in children over 2 years of age, and especially: travellers to

  10. 3 SG/TETSD/0118/SPC1210 Women of childbearing age or pregnant women that have not yet been immunized must have 2 successive injections at least 4 weeks apart, the first one shall preferably be administered 90 days

  1. People also search for